scholarly article | Q13442814 |
P2093 | author name string | Yuan Zhang | |
Yufeng Liu | |||
Xueju Xu | |||
P2860 | cites work | Epidemiology of childhood cancer | Q22252247 |
The prognostic and functional role of microRNAs in acute myeloid leukemia | Q27693865 | ||
MicroRNAs: genomics, biogenesis, mechanism, and function | Q27861070 | ||
Multidrug resistance in cancer: role of ATP-dependent transporters | Q28208049 | ||
Treatment of relapsed and refractory acute myelogenous leukemia | Q33864571 | ||
Multidrug resistance in haematological malignancies. | Q33917879 | ||
HMGB1-mediated autophagy promotes docetaxel resistance in human lung adenocarcinoma | Q34017957 | ||
Targeting microRNAs in cancer: rationale, strategies and challenges | Q34141089 | ||
HMGB1 release and redox regulates autophagy and apoptosis in cancer cells | Q34154797 | ||
Biology, risk stratification, and therapy of pediatric acute leukemias: an update | Q34764504 | ||
Upregulation of microRNA-125b contributes to leukemogenesis and increases drug resistance in pediatric acute promyelocytic leukemia | Q35290367 | ||
Upregulation of microRNA-126-5p is associated with drug resistance to cytarabine and poor prognosis in AML patients | Q35342968 | ||
MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2 | Q35832262 | ||
Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters. | Q35919726 | ||
HMGB1-mediated autophagy modulates sensitivity of colorectal cancer cells to oxaliplatin via MEK/ERK signaling pathway | Q36212999 | ||
MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma | Q36261535 | ||
Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy | Q36879748 | ||
CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia | Q36891005 | ||
The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents | Q36997966 | ||
Role of microRNA in anticancer drug resistance | Q37563160 | ||
Upregulation of miR-99a is associated with poor prognosis of acute myeloid leukemia and promotes myeloid leukemia cell expansion | Q37718496 | ||
Autophagy as a mediator of chemotherapy-induced cell death in cancer | Q37894277 | ||
Phytochemicals as chemosensitizers: from molecular mechanism to clinical significance | Q38032605 | ||
The role of decitabine for the treatment of acute myeloid leukemia | Q38056891 | ||
Acute myeloid leukemia: 2013 update on risk-stratification and management | Q38092771 | ||
Role of drug transport and metabolism in the chemoresistance of acute myeloid leukemia | Q38576716 | ||
MicroRNA-142-3p inhibits hypoxia/reoxygenation‑induced apoptosis and fibrosis of cardiomyocytes by targeting high mobility group box 1. | Q38724161 | ||
Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis | Q38867860 | ||
MicroRNA-142-3p inhibits cell proliferation in human acute lymphoblastic leukemia by targeting the MLL-AF4 oncogene | Q39093042 | ||
MicroRNA-29a induces resistance to gemcitabine through the Wnt/β-catenin signaling pathway in pancreatic cancer cells | Q39117777 | ||
MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia. | Q39366224 | ||
Autophagy-mediated HMGB1 release antagonizes apoptosis of gastric cancer cells induced by vincristine via transcriptional regulation of Mcl-1. | Q39438867 | ||
An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-α and cAMP/PKA pathways | Q39461997 | ||
Genomics of primary chemoresistance and remission induction failure in paediatric and adult acute myeloid leukaemia | Q40526958 | ||
MicroRNA-183 promotes cell proliferation via regulating programmed cell death 6 in pediatric acute myeloid leukemia | Q40542758 | ||
Modulation of P-glycoprotein expression and function by curcumin in multidrug-resistant human KB cells | Q40712197 | ||
Induction of autophagy by drug-resistant esophageal cancer cells promotes their survival and recovery following treatment with chemotherapeutics | Q41933492 | ||
DAMP-mediated autophagy contributes to drug resistance | Q42066148 | ||
Upregulation of microRNA-375 is associated with poor prognosis in pediatric acute myeloid leukemia | Q46679788 | ||
MicroRNA-142-3p Inhibits Chondrocyte Apoptosis and Inflammation in Osteoarthritis by Targeting HMGB1. | Q48146266 | ||
miR-181a promotes G1/S transition and cell proliferation in pediatric acute myeloid leukemia by targeting ATM. | Q52934924 | ||
A network including PU.1, Vav1 and miR-142-3p sustains ATRA-induced differentiation of acute promyelocytic leukemia cells - a short report. | Q54147578 | ||
miR-29a and miR-142-3p downregulation and diagnostic implication in human acute myeloid leukemia. | Q54364486 | ||
HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells | Q54645430 | ||
MicroRNA dysregulation in acute myeloid leukemia | Q86728526 | ||
[MicroRNA-10a expression in FAB different subtype of acute myeloid leukemia and its relationship with drug resistance] | Q86748370 | ||
P433 | issue | 3 | |
P921 | main subject | leukemia | Q29496 |
autophagy | Q288322 | ||
P304 | page(s) | 410-418 | |
P577 | publication date | 2017-04-23 | |
P1433 | published in | Translational Oncology | Q26839583 |
P1476 | title | Upregulation of miR-142-3p Improves Drug Sensitivity of Acute Myelogenous Leukemia through Reducing P-Glycoprotein and Repressing Autophagy by Targeting HMGB1 | |
P478 | volume | 10 |
Q55299232 | High mobility group box 1 (HMGB1) acts as an "alarmin" to promote acute myeloid leukaemia progression. |
Q41024459 | Identification of novel diagnostic and prognostic miRNA signatures in endometrial cancer |
Q92404751 | Johnny on the Spot-Chronic Inflammation Is Driven by HMGB1 |
Q97540690 | MiR-142-3p enhances chemosensitivity of breast cancer cells and inhibits autophagy by targeting HMGB1 |
Q55021852 | MiR-142-3p is downregulated in aggressive p53 mutant mouse models of pancreatic ductal adenocarcinoma by hypermethylation of its locus. |
Q92923691 | MiRNAs as Novel Adipokines: Obesity-Related Circulating MiRNAs Influence Chemosensitivity in Cancer Patients |
Q49521797 | MicroRNA, an Antisense RNA, in Sensing Myeloid Malignancies |
Q55085393 | MicroRNA-142-3p inhibits cell proliferation and chemoresistance in ovarian cancer via targeting sirtuin 1. |
Q61446203 | Overexpression of miR-758 inhibited proliferation, migration, invasion, and promoted apoptosis of non-small cell lung cancer cells by negatively regulating HMGB |
Q60924219 | The progression of HMGB1-induced autophagy in cancer biology |
Q49830478 | miR-142-3p regulates autophagy by targeting ATG16L1 in thymic-derived regulatory T cell (tTreg). |
Search more.